Predictability of OSA With a Subjective Screening Scale (OSASSS1)
NCT ID: NCT06092710
Last Updated: 2025-06-03
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
112 participants
OBSERVATIONAL
2023-01-01
2024-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Diurnal Evaluation of OSA Upper Airway Collapsibility and Muscle Responsiveness
NCT06334601
Multidimensional System as Predictor of Outcomes in Obstructive Sleep Apnea: The OSA-SCORE
NCT01175421
Precision OSA Therapy Based on Phenotypes and Endotypes
NCT06825923
Neurocognitive Function After Therapy of OSAS
NCT02505620
Home Nasal Pressure for Sleep Apnea Management in Primary Case
NCT02141165
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* polysomnography and sleep survey realized at the Center for Sleep Medicine André RENARD, without any informations of the results for the experience group
* sleep survey with no sleep trouble found for the control group
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
study group with PSG and sleep survey
the study group will be recruited after their polysomnography but before its results, so patients and investigators will not have any data about Apnea Hypopnea Index (AHI) and sleep survey. they will experiment their subjective perception of air flow through their airways with the guidance of a manual therapist during a 15 minutes protocol
neuro-sensorial subjective evaluation of the airways collapsibility
verbal and manual guidance of subjects from a therapist to experiment the subjective perception of the air flow through their airways and airways collapsibility
control group with sleep survey
the control group will be recruited after a sleep survey with no sleep disorder. they will experiment their subjective perception of air flow through their airways with the guidance of a manual therapist during a 15 minutes protocol
neuro-sensorial subjective evaluation of the airways collapsibility
verbal and manual guidance of subjects from a therapist to experiment the subjective perception of the air flow through their airways and airways collapsibility
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
neuro-sensorial subjective evaluation of the airways collapsibility
verbal and manual guidance of subjects from a therapist to experiment the subjective perception of the air flow through their airways and airways collapsibility
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* subjects who have performed a PSG at the sleep medicine center André Renard for the study group
* subjects with no sleep disorder on sleep survey for the control group
* Subjects who agree to comply with the requirements of the study.
* Subjects who are of age (and know how to read and write) who have given their informed, explicit consent in advance to any procedure related to the trial, the study or the investigation conducted on human beings, with the objective of developing knowledge specific to the exercise of health care professions, as set out in Royal Decree No. 78 of 10 November 1967 on the practice of the health care professions (Act of 27 December 2005)
Exclusion Criteria
* subjects with trauma within the last 72 hours
* subjects who already benefit from OSA treatment
* subjects with known perceptual disorders, for example post-stroke
* subjects with current or recent chemotherapy and radiotherapy treatment
* Pregnant women
* Criteria related to prior or concurrent treatments:
Treatment with antipsychotics, anxiolytics, soporifics or muscle relaxants started within the two months preceding the study.
Treatment with intraoral implants during the study or in the two months preceding the study
18 Years
77 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
PIRON Alain, Osteopath - physiotherapist
UNKNOWN
LACROIX Alain, neurologist, MD, PhD
UNKNOWN
CHAKAR Bassam, neurologist, MD, PhD
UNKNOWN
Center for Sleep Medicine - Clinique André Renard
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
GARCION Cédric
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Alain LACROIX, Neurologist, PhD
Role: STUDY_CHAIR
Center of Sleep Medecine - Clinique André Renard
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre de médecine du sommeil- Clinique André Renard
Herstal, Liège, Belgium
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol, Statistical Analysis Plan, and Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
OSASSS1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.